Asset
Bictegravir Sodium
Gilead Sciences Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 210251 | NDA | GILEAD SCIENCES INC |
Marketed products (2)
- BIKTARVY
- BIKTARVY